当前位置:首页 - 行情中心 - 华海药业(600521) - 财务分析 - 现金流量表

华海药业

(600521)

  

流通市值:254.98亿  总市值:254.98亿
流通股本:14.97亿   总股本:14.97亿

现金流量表

报告期2025-09-302025-06-302025-03-312024-12-31
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金6,615,578,877.094,433,984,374.732,294,859,508.89,035,678,576.67
  收到的税费返还111,725,483.4157,310,887.5114,498,857.71240,360,732.18
  收到其他与经营活动有关的现金173,991,588.18106,817,061.3530,640,225.51291,206,417.02
  经营活动现金流入小计6,901,295,948.684,598,112,323.592,339,998,592.029,567,245,725.87
  购买商品、接受劳务支付的现金2,515,392,005.491,626,867,295.49770,594,306.262,333,664,987.55
  支付给职工以及为职工支付的现金1,377,650,514.37950,118,265.94531,009,002.341,664,807,572.34
  支付的各项税费498,566,565.7418,875,420242,961,786.49808,671,410.35
  支付其他与经营活动有关的现金1,857,300,190.981,232,613,629.63600,325,838.072,587,437,831.82
  经营活动现金流出小计6,248,909,276.544,228,474,611.062,144,890,933.167,394,581,802.06
  经营活动产生的现金流量净额652,386,672.14369,637,712.53195,107,658.862,172,663,923.81
二、投资活动产生的现金流量:
  收回投资收到的现金116,266,648.6--6,050,627.35
  取得投资收益收到的现金159,980.78159,980.7834,013.7462,253.22
  处置固定资产、无形资产和其他长期资产收回的现金净额3,042,212.21,194,46033,0005,197,349.52
  收到的其他与投资活动有关的现金75,150,00075,150,00020,000,00020,000,000
  投资活动现金流入小计194,618,841.5876,504,440.7820,067,013.731,710,230.09
  购建固定资产、无形资产和其他长期资产支付的现金1,184,831,134.49770,274,761.71385,576,040.731,853,335,193.38
  投资支付的现金30,000,00030,000,00021,500,00078,620,923.74
  支付其他与投资活动有关的现金89,150,00075,150,00045,150,00020,030,135.18
  投资活动现金流出小计1,303,981,134.49875,424,761.71452,226,040.731,951,986,252.3
  投资活动产生的现金流量净额-1,109,362,292.91-798,920,320.93-432,159,027.03-1,920,276,022.21
三、筹资活动产生的现金流量:
  吸收投资收到的现金591,515,088.97591,515,088.97591,515,088.97-
  取得借款收到的现金3,454,074,156.911,353,233,056.91945,986,9806,201,877,610
  收到其他与筹资活动有关的现金200,000,000200,000,000200,000,000-
  筹资活动现金流入小计4,245,589,245.882,144,748,145.881,737,502,068.976,201,877,610
  偿还债务支付的现金3,372,511,3831,517,095,000740,040,0005,615,552,349.84
  分配股利、利润或偿付利息支付的现金491,179,385.9684,217,751.9335,494,312.1506,835,414.5
  其中:子公司支付给少数股东的股利、利润11,870,802.511,870,802.5-31,470,802.5
  支付其他与筹资活动有关的现金24,705,404.2814,392,338.636,339,157.78212,401,911.93
  筹资活动现金流出小计3,888,396,173.241,615,705,090.56781,873,469.886,334,789,676.27
  筹资活动产生的现金流量净额357,193,072.64529,043,055.32955,628,599.09-132,912,066.27
四、汇率变动对现金及现金等价物的影响-10,772,784.367,777,954.175,149,356.7451,158,021.95
五、现金及现金等价物净增加额-110,555,332.49107,538,401.09723,726,587.66170,633,857.28
  加:期初现金及现金等价物余额1,477,600,220.011,477,600,220.011,477,600,220.011,306,966,362.73
  期末现金及现金等价物余额1,367,044,887.521,585,138,621.12,201,326,807.671,477,600,220.01
补充资料:
  净利润-405,158,861.54-1,107,463,116.83
  资产减值准备-54,290,859.75-122,874,355.27
  固定资产和投资性房地产折旧-428,986,750.01-803,234,363.56
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧-428,986,750.01-803,234,363.56
  无形资产摊销-60,441,819.91-113,539,469.6
  长期待摊费用摊销-6,901,608.96-15,804,713.53
  处置固定资产、无形资产和其他长期资产的损失-14,072.93--2,333,721.93
  固定资产报废损失-2,626,083.63-8,709,957.24
  公允价值变动损失--32,699,755.78-69,493,156.45
  财务费用-110,204,782.05-139,337,388.45
  投资损失-12,094,720.76-28,227,510.13
  递延所得税-1,917,077.02--17,682,685.13
  其中:递延所得税资产减少-1,917,077.02--17,682,685.13
  存货的减少--233,596,825.81--78,327,395.16
  经营性应收项目的减少--135,192,077.57--786,087,193.98
  经营性应付项目的增加--330,549,917.98-597,684,896.15
  其他-6,457,221.72-14,142,417.74
  现金的期末余额-1,585,138,621.1-1,477,600,220.01
  减:现金的期初余额-1,477,600,220.01-1,306,966,362.73
  现金及现金等价物的净增加额-107,538,401.09-170,633,857.28
公告日期2025-10-312025-08-262025-04-302025-04-30
审计意见(境内)标准无保留意见
TOP↑